Lipoprotein (a).
Our understanding of the pathophysiological role of lipoprotein (a) in cardiovascular disease and its clinical importance has improved, but there are still gaps in our knowledge and analytical performance that hinder the appropriate management of patients. Further information about the physiological functions of lipoprotein (a), if any, and its interactions with other risk factors is required.
Sullivan
D R
DR
Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
D001161:Arteriosclerosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D017270:Lipoprotein(a) / Q000009:adverse effects / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D012307:Risk Factors
D017270:Lipoprotein(a); D008077:Lipoproteins, LDL